Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples